发明名称 TRANSDERMAL ADMINISTRATION OF OXYBUTYNIN
摘要 The present invention is directed to the transdermal administration of oxybutynin together with a suitable permeation en- hancer. The invention includes a transdermal drug delivery device comprising a matrix adapted to be placed in oxybutynin- and permeation enhancer-transmitting relation with the skin site. The matrix contains sufficient amounts of a permeation enhancer and of oxybutynin, in combination, to continuously administer to the skin for a predetermined period of time the oxybutynin to provide an effective therapeutic result. The invention is also directed to a method for the transdermal administration of a thera- peutically effective amount of oxybutynin together with a skin permeation- enhancing amount of a suitable permeation enhancer.
申请公布号 CA2132865(C) 申请公布日期 2003.12.02
申请号 CA19932132865 申请日期 1993.05.13
申请人 ALZA CORPORATION 发明人 LEE, EUN S.;NEDBERGE, DIANE E.;YUM, SU I.
分类号 A61K9/00;A61K9/70;A61K31/135;A61K31/215;A61K31/216;A61K47/10;A61K47/14;A61K47/34;A61P13/02;A61P15/00;A61P25/00;(IPC1-7):A61K47/14;A61K31/22 主分类号 A61K9/00
代理机构 代理人
主权项
地址